PhenomeX Balance Sheet Health
Financial Health criteria checks 4/6
PhenomeX has a total shareholder equity of $111.3M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $178.3M and $67.1M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$30.96m |
| Equity | US$111.28m |
| Total liabilities | US$67.05m |
| Total assets | US$178.33m |
Recent financial health updates
Recent updates
Analyst Forecasts Just Became More Bearish On PhenomeX Inc. (NASDAQ:CELL)
May 16
PhenomeX Inc.'s (NASDAQ:CELL) Subdued P/S Might Signal An Opportunity
Apr 17Analysts Just Made A Major Revision To Their Berkeley Lights, Inc. (NASDAQ:BLI) Revenue Forecasts
Aug 15Mehul Joshi joins Berkeley Lights as CFO
Jul 25Berkeley Lights Grows Revenue But Operating Losses Mount
Dec 09Are Investors Undervaluing Berkeley Lights, Inc. (NASDAQ:BLI) By 49%?
Nov 07Berkeley Lights: Short Seller Report Raises A Few Legitimate Questions
Sep 23Berkeley Lights: Optofluidic Technology Presents Strong Upside, May Redefine Therapeutic Development
Jun 09Berkeley Lights Q1 2021 Earnings Preview
May 10Financial Position Analysis
Short Term Liabilities: CELL's short term assets ($94.8M) exceed its short term liabilities ($42.2M).
Long Term Liabilities: CELL's short term assets ($94.8M) exceed its long term liabilities ($24.8M).
Debt to Equity History and Analysis
Debt Level: CELL is debt free.
Reducing Debt: CELL had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: CELL has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: CELL has less than a year of cash runway if free cash flow continues to reduce at historical rates of 26.9% each year